Geisinger has launched a new study that aims to gain more information on a novel technique to detect flare-ups or exacerbations of chronic obstructive pulmonary disease (COPD) in patients. The method being examined in the study is an algorithm for vocal biomarkers developed by Healthymize, a company that develops artificial intelligence-based voice analysis technology for diseases. This is an Investigator Sponsored Study supported by a grant from GSK. COPD is a progressive lung disease that makes it difficult to breathe. The two main forms of COPD are chronic bronchitis and emphysema, both of which damage your airways and interfere with your ability to absorb oxygen and release carbon dioxide.
Making Health Care Better
The Alliance of Community Health Plans is a national leadership organization bringing together innovative health plans and provider groups that are among America’s best at delivering affordable, high-quality coverage and care. Our plans are shaping the future of health care - driving better health outcomes, building healthier communities and inspiring an entire industry to do better.